Skip navigation

COVID-19 in Africa: an ovarian victory?

COVID-19 in Africa: an ovarian victory?

Dufailu, Osman ORCID logoORCID: https://orcid.org/0000-0002-8291-9832, Afriyie-Asante, Afrakoma, Gyan, Bernard, Kwabena, David Adu, Yeboah, Helena, Ntiakoh, Frank and Asare-Werehene, Meshach (2021) COVID-19 in Africa: an ovarian victory? Journal of Ovarian Research, 14 (70). pp. 1-13. ISSN 1757-2215 (doi:10.1186/s13048-021-00820-1)

[thumbnail of Publisher VoR]
Preview
PDF (Publisher VoR)
35974_DUFAILU_COVID_19_in_Africa_An_ovarian_victory.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mainly attacks the respiratory system and is characterized by pneumonia, cytokine storm, coagulation disorders and severe immune downregulation. Although public health experts predicted worst outcomes in Africa, the incidence, hospitalization and mortality rates have been lower in Africa compared to other continents. Interestingly, lower incidence and mortality rates have been observed in women from Africa compared to their cohorts from other continents. Also, in the US non-Hispanic Black females have lower COVID-19 and death rates compared to their white counterparts. It’s unclear why this significant difference exists; however, the ovarian function, genetics and immunological statuses could play a major role. Women of African descent have elevated levels of estrogen compared with Caucasians hence we anticipate that estrogen might offer some protection against the SARS-CoV-2 infections. The racial differences in lifestyle, age and inaccessibility to contraceptive usage might also play a role. Here, we provide insight on how the high levels of estrogen in African women might contribute to the lower cases and fatalities in Africa. Specifically, estrogen might offer protection against COVID-19 by suppressing hyper-production of cytokines, promoting anti-inflammatory cytokines, stimulating antibody production and suppressing endoplasmic reticulum (ER) stress. This will as well provide useful information on how future pandemics could be managed using Africa as a case study.

Item Type: Article
Uncontrolled Keywords: Africa; COVID-19; Estrogen; mortality rate; ovary; pro-inflammation cytokine; SARS-CoV-2
Subjects: Q Science > Q Science (General)
Q Science > QR Microbiology > QR180 Immunology
Faculty / School / Research Centre / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > School of Science (SCI)
Last Modified: 07 Nov 2023 09:24
URI: http://gala.gre.ac.uk/id/eprint/35974

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics